Is The Sudden Onset of Dizziness A Symptom of Acute Liver Dysfunction?
- Conditions
- Dizziness
- Interventions
- Other: LFTs
- Registration Number
- NCT02733549
- Lead Sponsor
- Adiyaman University Research Hospital
- Brief Summary
Dizziness is one of the most common complaints among patients admitted to the emergency department (ED). In most cases, the etiology remains unclear. Dizziness has a broad differential diagnosis. The initial symptoms of ALD can include many general complaints. Aim of this study is to investigate whether SOD is a symptom of ALD, the necessity of liver function tests for patients with SOD in the ED, and a cost analysis of liver function tests.
- Detailed Description
Dizziness is one of the most common complaints among patients admitted to the emergency department (ED). In most cases, the etiology remains unclear. Dizziness has a broad differential diagnosis. The initial symptoms of ALD can include many general complaints. The diagnosis of acute liver dysfunction (ALD) can usually be made by initial symptoms, physical examination, and biochemical tests, including liver function tests (LFTs) with high sensitivity and specificity. LFTs include albumin, bilirubin, coagulation factors (Activated Partial Thromboplastin Time (aPTT) and International Normalized Ratio (INR)), and liver enzymes, such as alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphates (ALP), and y-glutamyl transpeptidase (GGT), which are marker of hepatic damage. Aim of this study is to investigate whether SOD is a symptom of ALD, the necessity of LFTs for patients with SOD in the ED, and a cost analysis of LFTs.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 198
- Adult patients who were experiencing sudden onset dizziness of unknown etiology for the first time were included in the study
- Patients with a history of chronic diseases such as any liver disease,diabetes mellitus, hypertension,congestive heart failure, hepatitis B or C infection
- Patients with any central dizziness attacks
- Patients with hemodynamically unstable and emesis;
- Patients receiving drugs that could affect liver function tests, such as, acetaminophen, antibiotics, oral contraceptives, antihypertensive drugs (e.g., angiotensinconverting enzyme inhibitors), or hormones (e.g.,estrogen)
- Patients who was experienced dizziness with systemic diseases
- Patients with any neurological disorders
- Patient who do not want to participate in the study
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description patient LFTs Patients with sudden onset dizziness (SOD) analysed LFTs control LFTs The control group with 98 healthy volunteer analysed LFTs
- Primary Outcome Measures
Name Time Method LFTs serum levels by biochemical method ALT, AST, ALP, GGT, total bilirubin, conjugated bilirubin, albumin, INR, aPTT, and Platelet count (PC) 5 months The serum levels of LFTs will obtained by the laboratory analysis of blood samples of each participant.
- Secondary Outcome Measures
Name Time Method The cost calculation for the LFTs 5 months The cost for the LFTs will be calculated with financial data in invoices which will obtained from the hospital invoicing service.
Trial Locations
- Locations (1)
Adiyaman University Research Hospital
🇹🇷Adiyaman, Central, Turkey